KalVista Pharmaceuticals, Inc. (NASDAQ:KALV – Get Free Report) insider Edward P. Feener sold 8,088 shares of the company’s stock in a transaction that occurred on Monday, May 20th. The stock was sold at an average price of $11.76, for a total value of $95,114.88. Following the sale, the insider now directly owns 72,858 shares in […]
KalVista Pharmaceuticals (NASDAQ:KALV) Receives "Buy" Rating from Needham & Company LLC themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
KalVista Pharmaceuticals, Inc. (NASDAQ:KALV – Get Free Report) rose 6.8% on Wednesday . The stock traded as high as $12.13 and last traded at $12.12. Approximately 71,232 shares traded hands during trading, a decline of 90% from the average daily volume of 700,371 shares. The stock had previously closed at $11.35. Wall Street Analysts Forecast […]
KalVista Pharmaceuticals, Inc. (NASDAQ:KALV – Get Free Report) rose 6.8% on Wednesday . The stock traded as high as $12.13 and last traded at $12.12. Approximately 71,232 shares traded hands during trading, a decline of 90% from the average daily volume of 700,371 shares. The stock had previously closed at $11.35. Wall Street Analysts Forecast […]
KalVista Pharmaceuticals (NASDAQ:KALV) Given New $24.00 Price Target at HC Wainwright themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.